Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare Conferences


DUBLIN, Nov. 12, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its corporate presentation will be webcast live at the Stifel 2019 Healthcare Conference on Tuesday, Nov. 19, 2019 at 1:15 p.m. ET (6:15 p.m. GMT) from New York. In addition, Alkermes' corporate presentation will be webcast live at the Jefferies London Healthcare Conference on Thursday, Nov. 21, 2019 at 4:00 p.m. GMT (11:00 a.m. ET) from London, U.K.  These presentations may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases and oncology. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for diseases that include schizophrenia, depression, addiction, multiple sclerosis, and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Contact:
Alex Braun
Investor Relations
+1 781 296 8493

Alkermes plc Logo

Logo - https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg


These press releases may also interest you

at 19:35
Paysign, Inc. , a vertically integrated provider of innovative prepaid card programs, digital banking and processing services for corporate, consumer and government applications, will discuss 2020 2nd Quarter earnings at 5:00 PM Eastern Time on...

at 19:30
The "The Global Market for Nanotechnology in Packaging" report has been added to ResearchAndMarkets.com's offering. Report contents include: Market drivers and trends for the use of nanomaterials in packaging. Market challenges for the use of...

at 19:16
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative...

at 18:45
The "Data Center Construction Market in Africa - Industry Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included1. What is the Africa...

at 18:05
BigCommerce Holdings, Inc. ("BigCommerce") today announced the closing of its initial public offering of 10,372,500 shares of its Series 1 common stock. The offering consisted of 7,877,500 shares of Series 1 common stock issued and sold by...

at 18:00
The "Security as a Service Market by Component (Solution and Service), Application Area (Network Security, Endpoint Security, Application Security, and Cloud), Organization Size, Vertical, and Region - Global Forecast to 2025" report has been added...



News published on 12 november 2019 at 16:01 and distributed by: